Immunovant, Inc.
Immunovant is a clinical-stage immunology company developing anti-FcRn targeted therapies for autoimmune diseases.
424B3Nov 12Latest SEC filing
Nov 9Latest story
November 2026
August 2026
Immunovant is a clinical-stage immunology company developing anti-FcRn targeted therapies for autoimmune diseases.